SEQUA Sequana Medical NV

0.6701USD0.6110 EUR · EBR0.00%Mkt Cap: 52.39M USDP/E: —

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offe…

Key Statistics

Company
Market Cap52.39M USD
Enterprise Value75.73M USD
Revenue (TTM)0 USD
Gross Profit86.71K USD
Net Income (TTM)-48.98M USD
Revenue/Share0.00 USD
Last Price0.6701 USD
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees48
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0974340722
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG—
EV/EBITDA-4.01
EV/Revenue—
P/SInfinity
P/B-0.89
EPS (TTM)-1.35 USD
EPS (Forward)-0.40 USD
52W Range
0.504537% of range0.9487
52W High0.9487 USD
52W Low0.5045 USD
Profitability
Gross Margin74.94%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-42325.70%
ROE100.62%
ROA-449.06%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.22M USD
CapEx (TTM)104.34K USD
FCF Margin—
FCF Yield-27.24%
Net Debt37.39M USD
Net Debt/EBITDA-1.98
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.90
Current Ratio0.20
Quick Ratio0.15
Book Value/Sh-0.75 USD
Cash/Share0.14 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.78.17M
Float40.72M
Insiders9.59%
Institutions30.20%
Technical
SMA 500.6701 (+0.0%)
SMA 2000.6454 (+3.8%)
Beta-0.32
S&P 52W Chg12.00%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)68.5
MACD0.0000
MACD Signal0.0000
MACD Hist.-0.0000
BB Upper0.6701 USD
BB Middle0.6701 USD
BB Lower0.6701 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—

About Sequana Medical (EBR: SEQUA)

›

Sequana Medical (EBR: SEQUA) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 48 employees.

The shares were at 0.6110 EUR on 18 November 2026, down 6.4% over 52 weeks. Its 52-week range is 0.4600 EUR to 0.8650 EUR: the price is 29.4% below the high and 32.8% above the low.

Its market capitalisation is 47.76M EUR.

Sequana Medical reports return on equity of 100.6% and an operating margin of 0.0%.

Its debt exceeds its cash by 34.09M EUR. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.